Last reviewed · How we verify
Cultured Thymus Tissue — Competitive Intelligence Brief
marketed
Thymic extract/cultured tissue immunotherapy
Immunology
Biologic
Live · refreshed every 30 min
Target snapshot
Cultured Thymus Tissue (Cultured Thymus Tissue) — Sumitomo Pharma Switzerland GmbH. Cultured thymus tissue provides thymic factors and hormones that support immune system development and T-cell maturation.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Cultured Thymus Tissue TARGET | Cultured Thymus Tissue | Sumitomo Pharma Switzerland GmbH | marketed | Thymic extract/cultured tissue immunotherapy |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Thymic extract/cultured tissue immunotherapy class)
- Sumitomo Pharma Switzerland GmbH · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Cultured Thymus Tissue CI watch — RSS
- Cultured Thymus Tissue CI watch — Atom
- Cultured Thymus Tissue CI watch — JSON
- Cultured Thymus Tissue alone — RSS
- Whole Thymic extract/cultured tissue immunotherapy class — RSS
Cite this brief
Drug Landscape (2026). Cultured Thymus Tissue — Competitive Intelligence Brief. https://druglandscape.com/ci/cultured-thymus-tissue. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab